Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT06137794
Eligibility Criteria:
Inclusion Criteria:
* patients who are 18 years or older and have received a new diagnosis of paroxysmal, persistent, or permanent AF confirmed by electrocardiogram (ECG) or 24-hour Holter monitors
* must be willing to participate in the study and sign the informed consent
Exclusion Criteria:
* those who are pregnant
* those whohave experienced therapeutic or subtherapeutic bleeding complications in the last 6 months
* those who have severe renal insufficiency (creatinine clearance rate, CrCl ≤ 20 ml/min)
* those who have severe hepatic insufficiency (Child-Pugh ≥ 10 points)
* those who have severe heart failure (cardiac function New York Heart Association, NYHA grade IV and above)
* those who have severe infection and respiratory failure
* those who are unable to comply with the study requirements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT06137794
Study Brief:
Protocol Section:
NCT06137794